© Reuters. FILE PHOTO: A sign is pictured outside an Eli Lilly and Company pharmaceutical manufacturing plant at 50 ImClone Drive in Branchburg, New Jersey, March 5, 2021. Picture taken March 5, 2021. REUTERS/Mike Segar/File Photo
(Reuters) – Drugmaker Eli Lilly (NYSE:) and Co reported a near 40% rise in quarterly profit on Thursday, helped by strong demand for its top-selling diabetes drug and newer cancer treatments.
Net income rose to $1.90 billion, or $2.10 per share, in the first quarter ended March 31, from $1.36 billion, or $1.49 per share, a year ago.